Your password must be at least 8 characters and contain a number and letter.
Switching from PDE5i to Riociguat in the RESPITE Study: Effect on Right Heart FunctionRaymond Benza, MD
Rates of Hospitalization Associated with the Use of Aldosterone Receptor Antagonists in Patients with Pulmonary Arterial HypertensionMorgan Corkish, PharmD
OPUS Registry: Switching to Macitentan From Other Endothelin Receptor Antagonists (ERAs)Ashwin Ravichandran, MD, MPH, FACC
Intravenous Treprostinil Delivered by Implantable Pump for the Treatment of Pulmonary Arterial Hypertension - Report of First 11 CasesDror Rosengarten, MD
LVAD Does Not Improve Outcomes in Patients with Pulmonary Hypertension after Heart TransplantationChase Brown, MD
You must be logged in and own this session in order to